1. Home
  2. VABK vs VYGR Comparison

VABK vs VYGR Comparison

Compare VABK & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

N/A

Current Price

$42.60

Market Cap

231.3M

Sector

Finance

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.45

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
VYGR
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.3M
227.2M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
VABK
VYGR
Price
$42.60
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
4.4K
454.5K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.39%
N/A
EPS Growth
12.70
N/A
EPS
0.97
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
$43.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.37
$2.65
52 Week High
$48.58
$5.55

Technical Indicators

Market Signals
Indicator
VABK
VYGR
Relative Strength Index (RSI) 53.12 35.76
Support Level $38.18 $3.27
Resistance Level $43.98 $4.38
Average True Range (ATR) 1.09 0.26
MACD -0.23 -0.05
Stochastic Oscillator 15.79 7.73

Price Performance

Historical Comparison
VABK
VYGR

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: